MedTrace Logo

Testing of the Cancer Thriving and Surviving Breast Cancer Program

NCT03651921 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2020-08-24

No results posted yet for this study

Summary

The adjusted Cancer Thriving and Surviving Program (CTS) for women with breast cancer living in Switzerland (CTS-BC-CH) is a course of 7 weekly sessions of 2.5 - 3 hours led by trained peer-leaders (women with breast cancer experience). This pilot study aims to explore the reach of the CTS-BC-CH program (integrated into the clinical pathway) and to investigate its preliminary effectiveness with regard to Swiss breast cancer patients' self-efficacy and self-management.

Conditions

Interventions

BEHAVIORAL

CTS-BC-CH

CTS-BC-CH is a standardized program with 7 weekly group sessions (2.5. to 3 hours). The CTS-BC-CH focuses on building skills, sharing experiences, and support among the participants. Program elements are: Brainstorming, action plan formulation, action plan feedback, problem solving, and decision making.

Sponsors & Collaborators

  • Swiss Cancer League

    collaborator OTHER

  • Lindenhofgruppe AG

    collaborator INDUSTRY

  • Manuela Eicher

    lead OTHER

Principal Investigators

  • Manuela Eicher, Prof. Dr. · Institute of Higher Education and Reserach in Health Care - IUFRS University of Lausanne and University Hospital of Lausanne

  • Joerg Haselbeck, Dr. · Swiss Cancer League Berne; Formely: Careum Stiftung, Kompetenzzentrum Patientenbildung

  • Karin Ribi, Dr. phil. · International Breast Cancer Study Group (IBCSG)

  • Corinne Urech, Dr. phil. · University Hospital, Basel, Switzerland

  • Karin Holm · Patient Advocats for Cancer Reserach and Treamtment (Association PARCT)

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-12
Primary Completion
2019-08-15
Completion
2019-08-15

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03651921 on ClinicalTrials.gov